Teladoc Health Refutes SIRF Report Claims
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- S&P 500, Dow rise on Mideast deal hopes, SpaceX's historic debut
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil nears two-month lows on reports of imminent US-Iran peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Wall St set to gain on tech rebound, Middle East in focus
Teladoc (TDOC) Defended at Cowen
December 6, 2018 11:34 AM ESTCowen analyst Charles Rhyee defends Teladoc (NYSE: TDOC), saying they find allegations of misconduct without merit.
Rhyee commented, "We believe the negative stock reaction following a report alleging misconduct of an executive is unwarranted. The allegations from 2016 were addressed at the... More
